AUTL - Autolus Therapeutics plc American Depositary Share -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Autolus Therapeutics plc American Depositary Share
IPO Date: June 22, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $516.36M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.33 | 4.00%
Avg Daily Range (30 D): $0.08 | 3.78%
Avg Daily Range (90 D): $0.07 | 3.74%
Institutional Daily Volume
Avg Daily Volume: .91M
Avg Daily Volume (30 D): 2.29M
Avg Daily Volume (90 D): 1.76M
Trade Size
Avg Trade Size (Sh.): 222
Avg Trade Size (Sh.) (30 D): 229
Avg Trade Size (Sh.) (90 D): 251
Institutional Trades
Total Institutional Trades: 416
Avg Institutional Trade: $1.76M
Avg Institutional Trade (30 D): $.89M
Avg Institutional Trade (90 D): $.89M
Avg Institutional Trade Volume: .39M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.19M
Avg Closing Trade (30 D): $.89M
Avg Closing Trade (90 D): $.89M
Avg Closing Volume: 240.68K
 
News
Sep 16, 2026 @ 8:55 AM
CAR T-Cell Therapy for Non-Hodgkin’s Lympho...
Source: Researchandmarkets.Com
Sep 16, 2026 @ 8:54 AM
CAR T-Cell Therapy for Acute Lymphoblastic Leukemi...
Source: Researchandmarkets.Com
Sep 14, 2026 @ 5:00 PM
Lupus Nephritis Market on a Growth Trajectory at a...
Source: Delveinsight
Jun 12, 2026 @ 8:00 AM
Autolus Therapeutics Receives Prix Galien UK Award...
Source: Na
May 27, 2026 @ 11:00 AM
Autolus Therapeutics to Participate in Upcoming In...
Source: Na
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.06 $-.15 $-.27
Diluted EPS $-1.06 $-.15 $-.27
Revenue $117.39M $45.69M $26.22M
Gross Profit $18.38M $25.22M $1.65M
Net Income / Loss $-280.16M $-39.11M $-71.6M
Operating Income / Loss $-247.44M $-43.84M $-59.51M
Cost of Revenue $99.01M $20.47M $24.57M
Net Cash Flow $47.58M $40.49M $26.78M
PE Ratio